跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Giotrif - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Giotrif
Approved
STANDARD
Giotrif
Boehringer Ingelheim Pharma GmbH & Co. KG
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
629aa8ca119ed49e
Company
Boehringer Ingelheim Pharma GmbH & Co. KG
Type
Standard
Approval Details
Approval Id
629aa8ca119ed49e
Drug Approval Philippines Name
Giotrif
Product Name
Giotrif
Registration Number
DR-XY43780
Brand Name
Giotrif
Generic Name
Afatinib (as dimaleate)
Dosage Form
Film-Coated Tablet
Dosage Strength
30 mg
Manufacturer
Boehringer Ingelheim Pharma GmbH & Co. KG
Importer
Boehringer Ingelheim (Phil.), Inc.
Distributor
Boehringer Ingelheim (Phil.), Inc.
Company Detail Path
/organization/boehringer-ingelheim-pharma-gmbh-and-co-kg
Issuance Date
28 August 2024
Expiry Date
07 October 2029
Pharmacologic Category
Antineoplastic Agent (Protein kinase inhibitor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
629aa8ca119ed49e
Type
Standard
Back to Philippines FDA Approvals